These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 3442568)

  • 1. [Synthesis and biological activity of peptides from interferon alpha A region 125-131].
    Rituma IR; Vegner RE; Afanas'eva GA; Kukaĭn EM; Chipens GI
    Bioorg Khim; 1987 Nov; 13(11):1496-500. PubMed ID: 3442568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of residues of the IFNAR1 chain of the type I human interferon receptor critical for ligand binding and biological activity.
    Cajean-Feroldi C; Nosal F; Nardeux PC; Gallet X; Guymarho J; Baychelier F; Sempé P; Tovey MG; Escary JL; Eid P
    Biochemistry; 2004 Oct; 43(39):12498-512. PubMed ID: 15449939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of interferon on antibody formation.
    Johnson HM
    Tex Rep Biol Med; 1981-1982; 41():411-9. PubMed ID: 6189207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type I interferon is a powerful inhibitor of in vivo HIV-1 infection and preserves human CD4(+) T cells from virus-induced depletion in SCID mice transplanted with human cells.
    Lapenta C; Santini SM; Proietti E; Rizza P; Logozzi M; Spada M; Parlato S; Fais S; Pitha PM; Belardelli F
    Virology; 1999 Oct; 263(1):78-88. PubMed ID: 10544084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and physicochemical characterization of major fragments of human leucocyte interferon alpha 1.
    Leist T; Thomas RM
    Biochemistry; 1984 Jun; 23(12):2541-7. PubMed ID: 6466597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single amino acid substitutions at conserved residues of human interferon-alpha can effect antiviral specific activity.
    Nisbet IT; Beilharz MW; Hertzog PJ; Tymms MJ; Linnane AW
    Biochem Int; 1985 Sep; 11(3):301-9. PubMed ID: 3904757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral administration of type-II collagen peptide 250-270 suppresses specific cellular and humoral immune response in collagen-induced arthritis.
    Zhu P; Li XY; Wang HK; Jia JF; Zheng ZH; Ding J; Fan CM
    Clin Immunol; 2007 Jan; 122(1):75-84. PubMed ID: 17045846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the carboxyl terminal peptides of human seminal plasma inhibin (HSPI). Chemical synthesis and in vivo biological activity of the disulfide loop peptide 67-94 of HSPI.
    Mahale SD; Sheth AR; Iyer KS
    Int J Pept Protein Res; 1993 Aug; 42(2):132-7. PubMed ID: 8407107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of the T suppressor circuit of delayed-type hypersensitivity by interferon.
    Knop J; Stremmer R; Taborski U; Freitag W; de Maeyer-Guignard J; Macher E
    J Immunol; 1984 Nov; 133(5):2412-6. PubMed ID: 6237149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early type I interferon-mediated signals on B cells specifically enhance antiviral humoral responses.
    Fink K; Lang KS; Manjarrez-Orduno N; Junt T; Senn BM; Holdener M; Akira S; Zinkernagel RM; Hengartner H
    Eur J Immunol; 2006 Aug; 36(8):2094-105. PubMed ID: 16810635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon-omega suppresses hepatitis B surface antigen production in human hepatoma cell line.
    Hajnická V; Fuchsberger N; Liptáková H; Stancek D; Kontsek P
    Acta Virol; 1996 Sep; 40(4):221-2. PubMed ID: 9014013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amino-terminal dimerization of peptides on the solid support. Synthesis and biological activity of the immunosuppressive HLA-DR fragments linked by poly(ethylene glycol)s.
    Biernat M; Stefanowicz P; Zimecki M; Szewczuk Z
    Bioconjug Chem; 2006; 17(5):1116-24. PubMed ID: 16984118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiestrogenic and anticancer activities of peptides derived from the active site of alpha-fetoprotein.
    Joseph LC; Bennett JA; Kirschner KN; Shields GC; Hughes J; Lostritto N; Jacobson HI; Andersen TT
    J Pept Sci; 2009 Apr; 15(4):319-25. PubMed ID: 19189271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant adenoviral vectors turn on the type I interferon system without inhibition of transgene expression and viral replication.
    Huarte E; Larrea E; Hernández-Alcoceba R; Alfaro C; Murillo O; Arina A; Tirapu I; Azpilicueta A; Hervás-Stubbs S; Bortolanza S; Pérez-Gracia JL; Civeira MP; Prieto J; Riezu-Boj JI; Melero I
    Mol Ther; 2006 Jul; 14(1):129-38. PubMed ID: 16627004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Influence of the synthetic peptide recognized by neutralizing antibody on IFN-induced biological responses].
    Hu R; Ma X; Wei K
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1999 Mar; 13(1):29-32. PubMed ID: 12759948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of novel cyclic altered peptide ligands of myelin basic protein MBP83-99 that modulate immune responses in SJL/J mice.
    Katsara M; Deraos G; Tselios T; Matsoukas J; Apostolopoulos V
    J Med Chem; 2008 Jul; 51(13):3971-8. PubMed ID: 18563891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fragment couplings with stepwise couplings in solid-phase synthesis. Synthesis of a fragment of human leukocyte interferon.
    Ljungqvist A; Folkers K
    Acta Chem Scand B; 1984; 38(5):375-9. PubMed ID: 6485677
    [No Abstract]   [Full Text] [Related]  

  • 18. Requirement for protein synthesis for induction of macrophage tumoricidal activity by IFN-alpha and IFN-beta but not by IFN-gamma.
    Blasi E; Herberman RB; Varesio L
    J Immunol; 1984 Jun; 132(6):3226-8. PubMed ID: 6725951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colostrinine: a proline-rich polypeptide from ovine colostrum is a modest cytokine inducer in human leukocytes.
    Inglot AD; Janusz M; Lisowski J
    Arch Immunol Ther Exp (Warsz); 1996; 44(4):215-24. PubMed ID: 9017161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-12 is both required and sufficient for initiating T cell reactivity to a class I-restricted tumor peptide (P815AB) following transfer of P815AB-pulsed dendritic cells.
    Bianchi R; Grohmann U; Belladonna ML; Silla S; Fallarino F; Ayroldi E; Fioretti MC; Puccetti P
    J Immunol; 1996 Aug; 157(4):1589-97. PubMed ID: 8759743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.